218 related articles for article (PubMed ID: 6343505)
41. The monoclonal antibodies against mouse macrophages.
Długońska H; Rüde E
Arch Immunol Ther Exp (Warsz); 1985; 33(4):573-80. PubMed ID: 3878697
[TBL] [Abstract][Full Text] [Related]
42. Improvement in the basic technology of electrofusion for generation of antibody-producing hybridomas.
Ohnishi K; Chiba J; Goto Y; Tokunaga T
J Immunol Methods; 1987 Jun; 100(1-2):181-9. PubMed ID: 3110294
[TBL] [Abstract][Full Text] [Related]
43. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
44. Characterization of heteromyeloma fusion partners which promote the outgrowth of porcine hybridomas.
Greenlee AR; Magnuson NS; Smith C; Butt BM; McKiernan AJ; Davis WC
Vet Immunol Immunopathol; 1990 Nov; 26(3):267-83. PubMed ID: 2264287
[TBL] [Abstract][Full Text] [Related]
45. Increased yields of IgG2a- and IgG3-secreting hybridomas after fusion of B cells from mice with autoimmune diseases.
Yin BW; Wong GY; Lloyd KO; Oettgen HF; Welt S
J Immunol Methods; 1991 Nov; 144(2):165-73. PubMed ID: 1960413
[TBL] [Abstract][Full Text] [Related]
46. Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6).
Bazin R; Lemieux R
J Immunol Methods; 1989 Jan; 116(2):245-9. PubMed ID: 2783446
[TBL] [Abstract][Full Text] [Related]
47. Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin.
Cairns E; Block J; Bell DA
J Clin Invest; 1984 Sep; 74(3):880-7. PubMed ID: 6470143
[TBL] [Abstract][Full Text] [Related]
48. A new human fusion partner, HK-128, for making human-human hybridomas producing monoclonal IgG antibodies.
Kawahara H; Yamada K; Shirahata S; Murakami H
Cytotechnology; 1990 Sep; 4(2):139-43. PubMed ID: 1367041
[TBL] [Abstract][Full Text] [Related]
49. Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions.
Alkan SS; Mestel F; Jiricka J; Blaser K
Hybridoma; 1987 Aug; 6(4):371-9. PubMed ID: 3623581
[TBL] [Abstract][Full Text] [Related]
50. [Production of human antitetanus antibodies by hybridomas].
Garchon HJ; Blancher A; Champommier F; Blanchard de Vaucouleurs A; Bach JF; Hainaut J
Rev Fr Transfus Immunohematol; 1983 Apr; 26(2):147-51. PubMed ID: 6879040
[TBL] [Abstract][Full Text] [Related]
51. Human monoclonal antibodies directed against ovarian carcinoma.
Werner M; Ahlert T; Bastert G
Gynecol Oncol; 1989 Aug; 34(2):148-54. PubMed ID: 2666283
[TBL] [Abstract][Full Text] [Related]
52. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
53. Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.
Lane HC; Shelhamer JH; Mostowski HS; Fauci AS
J Exp Med; 1982 Jan; 155(1):333-8. PubMed ID: 6976416
[TBL] [Abstract][Full Text] [Related]
54. Two chicken B cell lines resistant to ouabain for the production of chicken monoclonal antibodies.
Nishinaka S; Akiba H; Nakamura M; Suzuki K; Suzuki T; Tsubokura K; Horiuchi H; Furusawa S; Matsuda H
J Vet Med Sci; 1996 Nov; 58(11):1053-6. PubMed ID: 8959651
[TBL] [Abstract][Full Text] [Related]
55. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
Chiorazzi N; Wasserman RL; Kunkel HG
J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
[TBL] [Abstract][Full Text] [Related]
56. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
Strike LE; Devens BH; Lundak RL
J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
[TBL] [Abstract][Full Text] [Related]
57. Production of stable human-mouse hybridomas secreting monoclonal antibodies against Rh D and c antigens.
Rapaille A; François-Gérard C; Donnay D; Sondag-Thull D
Vox Sang; 1993; 64(3):161-6. PubMed ID: 8484248
[TBL] [Abstract][Full Text] [Related]
58. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
[TBL] [Abstract][Full Text] [Related]
59. Facilitated cell fusion for hybridoma production.
Conrad MK; Lo MM
Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
[No Abstract] [Full Text] [Related]
60. Generation of human monoclonal antibodies reactive with cellular antigens.
Cote RJ; Morrissey DM; Houghton AN; Beattie EJ; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1983 Apr; 80(7):2026-30. PubMed ID: 6572959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
